Company Profile

BioFire Diagnostics Inc (AKA: Idaho Technology Inc~biofire defense LLC)
Profile last edited on: 12/29/22      CAGE: 088J2      UEI: NHMDGM122546

Business Identifier: DNA analysis and genotyping
Year Founded
1990
First Award
2012
Latest Award
2014
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

390 Wakara Way
Salt Lake City, UT 84108
   (801) 736-6354
   info@biofiredx.com
   www.biofiredx.com
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

Formerly doing business as Idaho Technology, Inc., in 2012, management changed the name to BioFire Diagnostics, Inc. better to reflect the company's focus in molecular diagnostics and biosurveillance. In September 2013, the firm was then acquired by the French in vitro diagnostics firm BioMérieux. In January 2014 BioFire Diagnostics merged with bioMerieux better to serve their markets and customers, and meet government regulations on security and business ownership, BioFire Diagnostics split into two companies: BioFire Diagnostics and BioFire Defense. BioFire Diagnostics is now the Center of Excellence for Molecular Diagnostics and responsible for manufacturing, marketing and sales of the FilmArray system.BioFire is a clinical diagnostics company, developing, manufacturing, distributing, and selling diagnostic respiratory panels to hospital-based clinical laboratories in the United States and Europe. The company offers solutions for pathogen identification and DNA research, including DNA amplification, real-time thermocycling, Hi-Res Melting, mutation scanning, and genotyping. It provides Hi-Res Melting instruments, high multiplex PCR instruments, and real-time PCR instruments; freeze-dried reagents, DNA and RNA sample purification kits, master mixes, and melting dyes; reagents, buffers, and capillary tubes; and training and instrument accessories.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $452,630
Project Title: Rapid, Automated, Detection of Viral and Bacterial Pathogens Causing Meningitis
2012 1 NIH $262,052
Project Title: Rapid Comprehensive Identification Of Pneumonia Pathogens

Key People / Management

  Richard S Ajioka

  Dale Dale Brown -- Senior Vice President of Engineering and Instrumentation

  Deepika de Silva -- Senior Vice President of Biochemistry

  Eric Gorrell -- General Counsel

  Andrew Hemmert

  Rachel Jones -- Senior Vice President of Sales and Marketing

  Randy Rasmussen -- Director, President, Chief Operating Officer and Co-founder

  Kirk Ririe -- Chief Executive Officer, Director and Founder

  Carl Wittwer -- Chairman of the Board and Co-founder